Professor and Chair
Robert Wood Johnson Medical School
Department of Medicine
Medical Education Building, Rm 491
51 French Street
New Brunswick, NJ 08903-2681
Pituitary and pancreatic hormonal growth and regulation
As a physician-scientist, Wondisford’s well-funded research program focuses on pituitary and pancreatic hormonal growth and regulation. He is the inventor of the approach to synthesize recombinant human TSH, for which he holds two U.S. patents. Recombinant human TSH (Thyrogen) is FDA-approved for use in the diagnosis and treatment of patients with thyroid cancer.